8/3/2019 8.Plasmodial Infections (Malaria)
1/42
PLASMODIAL INFECTIONS (MALARIA)
Phylum: Protozoa
Sub-phylum: Apicomplexa (Sporozoa)
Infective agent:Plasmodium falciparum,
P. malariae,
P. ovale,P. vivax
8/3/2019 8.Plasmodial Infections (Malaria)
2/42
INTRODUCTION 1
Is a vector borne disease and the most importantparasitic disease of man.
It is a protozoan infection of RBCs and istransmitted by the blood feeding female
anopheline mosquitoes. Word Malaria comes from the Italians and literally
means bad air (Mal aria) and they believed thatit was caused by a bacteria Bacillus malariae.
It was the French who implicated parasites in thisinfection.
It is caused byPlasmodium sp.
8/3/2019 8.Plasmodial Infections (Malaria)
3/42
INTRODUCTION 2
Over 350m people are infected with about 13mdeaths each year mostly African children (90%)
4 species ofPlasmodiuminfect man and thesevaryin their innate virulence depending on the type
of RBCs they infect.
Plasmodium falciparum
P. ovale P. malariae P. vivax
Of these 4 common speciesP. vivax and P.falciparum accounts for 95%of infection.
Malaria is found throughout the tropics andP.
falciparum dominates in Africa.
8/3/2019 8.Plasmodial Infections (Malaria)
4/42
8/3/2019 8.Plasmodial Infections (Malaria)
5/42
Plasmodium vivax
Causes benign tertian malaria with a 48hr cycle.
It covers a large geographic range, more common in
South America, N. Africa, India but rare in South
Saharan Africa.
It tends to have a true relapse from the residual
liver stages.
It infects young RBCs.
Parasite density rarely exceed 50,000 / l of blood.
8/3/2019 8.Plasmodial Infections (Malaria)
6/42
Plasmodium ovale
Causes benign tertian malaria with a 48hr cycle.
It covers a narrow geographic range (it is quite rare
out side West Africa and South Pacific islands/regions)
It infects young RBCs
8/3/2019 8.Plasmodial Infections (Malaria)
7/42
Plasmodium malariae
Is responsible for quartan malaria with a 72hrcycle.
It covers a narrow geographic range; it is sporadicin distribution but relatively uncommonoutside Africa.
It infects older RBCs.
It is associated with recrudescenceand nephrotic
syndrome with no true relapse. P. vivaxand P. malariaeinfect about 12%or less
RBCs, P. ovaleinfects less than 2%of RBCs.
P. falciparuminfects or parasites up to 3040%.
Parasite density is about 10,000 / l of blood.
8/3/2019 8.Plasmodial Infections (Malaria)
8/42
INTRODUCTION 3
Almost all deaths due to malaria and severe diseasecondition are caused by P. falciparum
The other three parasites cause benign malarias and
severe disease condition with these species is un-
usual, however, occasionally patients with such
infection may die from rapture of an enlarged
spleen
8/3/2019 8.Plasmodial Infections (Malaria)
9/42
EPIDEMIOLOGY 1
A) THE VECTOR
The main vector is theAnopheles mosquito
Transmission does not occur at temperatures
below16 0C or above 33 0C because the
development of the parasite in the mosquito(sporogony) cannot occur.
These vectors show an important characteristic
vector competence i.e. longevity. This isbecause sporogony requires a weekor more to
occur depending on the temperature.
8/3/2019 8.Plasmodial Infections (Malaria)
10/42
EPIDEMIOLOGY 2
Transmission is directly proportional to the
Density of the vectorNumber of times of bites each day and also
The survival of the vector after feeding
Vectors differ in their natural density (abundance)/feeding / resulting behaviors / breeding site
preferences / flight ranges / choice of food (blood)/ vulnerability to environmental conditions and
insecticides. Anopheles gambiae is the most infective vector / are
tough / long lived / naturally occur in high
densities / bite humans frequently.
8/3/2019 8.Plasmodial Infections (Malaria)
11/42
EPIDEMIOLOGY 3
B) THE HUMAN HOST
Human behaviour plays a major role in thetransmission of malaria. There is the need forhuman reservoir of gametocytes to transmit theinfection.
In areas of high transmission, infants/young childrenare most susceptible than adults thus parasitedensities tend to be higher in children andgametocytes tend to be detected more frequently
in children. The younger age groups usually represent the main
reservoir group and the main recipients ofinfection.
8/3/2019 8.Plasmodial Infections (Malaria)
12/42
EPIDEMIOLOGY 4
Endemicity of infection is defined traditionally in
terms of the spleen or parasite rates (S/P) inchildren between 2- 9 yrs of age.
Hypo-endemic S/P is 010%
Meso-endemic S/P is 1015%
Hyper-endemic S/P is 5070%
Holo-endemic S/P is over 75%
In Holo and Hyper-endemic areas for Plasmodiumfalciparume.g. tropical Africa,people arerepeatedly infected throughout their lives.
8/3/2019 8.Plasmodial Infections (Malaria)
13/42
EPIDEMIOLOGY 5
Children who survive infection achieve a state of
premunitionwhere infections cause little or no
problems to host (children).
Premunition is therefore a form of immunity that
develops to control but not to prevent infection.
It is also known that non-immune adults visiting areas
of intense transmission tend to acquirepremunition
more rapidly than children.
Falciparum malaria infections are more severe in
pregnancyparticularly in primigravidae.
8/3/2019 8.Plasmodial Infections (Malaria)
14/42
CLINICAL EPIDEMIOLOGY 1
Babies tend to develop severe malaria infrequently, ifthey do, mortality is high.
Factors responsible for infrequent malaria in infantsinclude passive transfer of matenal immunity and
high haemoglobin F contentof infantserythrocytes, which retard parasite development.
Thus there may be lots of inoculation with
sporozoites in the 1st year of life but blood stageinfection may seldomly be severe.
In the 13yr group, falciparummalaria can causesevere anaemia.
8/3/2019 8.Plasmodial Infections (Malaria)
15/42
CLINICAL EPIDEMIOLOGY 2
In less intense or unstable transmission, the age
group severely affected extend to the older childrenleading to cerebral malaria
In Holo / Hyper endemic areas - indigenous
adultsnever develop severe malaria unless theymigrate or emigrate because usuallypremunition
prevents parasites from reaching dangerous levels.
Premunition is generally lowin areas where
transmission is infrequent.
Malaria transmission is usually seasonal, it is highin the rainy season; because coincides with theabundance of mosquiotoes.
8/3/2019 8.Plasmodial Infections (Malaria)
16/42
CLINICAL EPIDEMIOLOGY 3
Deforestation, population migration and changes in
agricultural practices have increased effect intransmission.
Epidemics are caused by migrations / introduction ofnew vectors or changes in the habits of thevectors
or human hosts. Thus malaria could be imported and this type of
malaria is often mis-diagnosed.
Transmission can also be by blood transfusion /transplantation or through the used of hypodermicneedles which are contaminated by prior use bydrug addicts.
8/3/2019 8.Plasmodial Infections (Malaria)
17/42
LIFE CYCLE 1
This is very complex and rich in morphological
details. There are two main stages:a) Human Stages
1) Pre-erythrocytic schizogony
2) Erythrocytic schizogony
3) Erythrocytic gametogonyb) Mosquito Stages
1) Fertilization, meiosis and ookineteformation
2) Formation of oocysts and sporogony Malaria provides an example of stage - development
specificity of invasion.
e.g. sporozoitesliver cells
merozoitesRBCs
8/3/2019 8.Plasmodial Infections (Malaria)
18/42
Life cycle of the malaria parasite 2
8/3/2019 8.Plasmodial Infections (Malaria)
19/42
LIFE CYCLE 3
A) PRE-ERYTHROCYTIC (Hepatic Phase)
Infection begins when the female anophelesmosquito inoculates plasmodial sporozoites into
the blood stream of man
These small motile sporozoites may be few in theinoculum (815) or can be about 100.
After inoculation, sporozoites enter the circulation
either directly or through the lymph channels andhome to the liver parenchyma cells. This happens
between (within) 45min all sporozoites would have
entered the liver or have been cleared.
8/3/2019 8.Plasmodial Infections (Malaria)
20/42
LIFE CYCLE 4
The sporozoites live in the hepatocytes (liver
cells) and begin asexual (schizogonic)reproduction.
Schizogonic phase can last between 5 days (P.
falciparum) to 15 days for (P. malariae)
In P. vivaxand P. ovaleinfections, aproportion
of the intrahepatic parasites do not develop but
go into a state of rest (quiescence) referred to asthe hypnozoites (latent forms) which become
active weeks / months later.
8/3/2019 8.Plasmodial Infections (Malaria)
21/42
LIFE CYCLE 4
These quiescent stages (sleeping stages) are
responsible for relapseswhich characterizethose P. vivax/ P. ovaleinfections.
During this asexual phase (schizogony),
multiplication occur producing many
thousands ofmerozoiteswhich are released
from ruptured infected hepatocytes.
This phase is asymptomatic for the human host.
In P. ovale and vivax, hypnozoites are latent forms
8/3/2019 8.Plasmodial Infections (Malaria)
22/42
LIFE CYCLE 5 B) ASEXUAL BLOOD STAGE DEVELOPMENT
Erythrocytic schizogonic phaseErythrocytic gametogonic phase
Released merozoites rapidly invade red cells.Attachment of parasite to RBC is facilitated byspecific RBC surface receptors.
e.g. In P. vivax- the duffy blood group antigen Fya orFyb 29, 30 . This antigen is absent in people from
the West Africans region and this explains absenceofP. vivaxinfection among these folks.
Receptors to P. falciparumhave been identified asglycophorins but receptors for P. malariaeand P. ovaleare not known.
8/3/2019 8.Plasmodial Infections (Malaria)
23/42
LIFE CYCLE 6
On entry the merozoites undergo severalmorphological changes and development from
Ring Forms (trophozoites) Schizonts Merozoites
In the early stages (less than 12hrs) the ring forms of
all 4 species appear to be identical or similarunder the microscope.
They look like a signet ring or in P. falciparumlike apair of earphones with darkly stained chromatin
in the nucleus, a circular rim of cytoplasm and acentral vacuolethey are motile.
As they growthey consume the contents of theerythrocytes, usually the haemoglobin.
8/3/2019 8.Plasmodial Infections (Malaria)
24/42
Ring forms of P.
falciparuminRBCs
8/3/2019 8.Plasmodial Infections (Malaria)
25/42
LIFE CYCLE 7
In about 2426hrs of development, P. falciparum
exhibits a high molecular weight strain variant
antigen on the surface of infected RBCs (knob-like
projections) which facilitate attachment to vascular
endothelium.
These RBCs disappear from circulation(sequestration) and attach to the walls of the
vessels (cytoadherence)a process called.
The other 3 species (benign malaria) do not cyto-adhere and all stages of these parasites are found
in the peripheral blood.
8/3/2019 8.Plasmodial Infections (Malaria)
26/42
LIFE CYCLE 8
P. vivaxduring growth enlarges the infected RBC
leading to the appearance of red granules (pigments)throughout the RBC called Schffners dots. Theseare also found in P. ovale.
P. malariaeproduces characteristic band forms as
parasites nature.
Infected RBCs rupture releasing merozoites between6 and 36 per RBC.
Asexual life cycle is 48 hrs (tertian malaria) for P.falicparum, P. vivax, P. ovaleand 72hrs (quartanmalaria for P. malariae)
8/3/2019 8.Plasmodial Infections (Malaria)
27/42
LIFE CYCLE 9
C) POST ERYTHROCYCTIC STAGE SEXUAL STAGESAND DEVELOPMENT IN THE MOSQUITO
After series of asexual cycles, a sub population ofparasites develops (by gametogomy)into sexualforms (gametocytes), which are long lived andmotile.
The process ofgametogony takes 4 days in P.vivaxinfections and more than 10 days in P.falciparum.
Upon ingestion ofmale and female gametocytesin a blood meal the parasites become activated.
They develop, multiply and fuse to form a zygote.
8/3/2019 8.Plasmodial Infections (Malaria)
28/42
Male and Female gametocytes of
P. falciparum
LIFE CYCLE 9
8/3/2019 8.Plasmodial Infections (Malaria)
29/42
LIFE CYCLE 9
Within 24hrs the enlarging zygote (ookinete)
becomes motile andpenetrates the walls of the
mosquitos mid gut (stomach) where it encysts
as an oocyst.
The oocyst finally raptures to release myriads of
sporozoites into the coelomic cavity of themosquito.
These sporozoites then migrate to the salivary
glands to await inoculation into the next host
Sporogony and takes between 835 days
depending on ambient temperature / species of
parasites / mosquito.
8/3/2019 8.Plasmodial Infections (Malaria)
30/42
HUMAN GENETICS AND MALARIA 1
Genetic polymorphism ofseveral human genes affect
entry / multiplication /survival / development ofmalaria parasites and this determines the outcome
of the infection.
Parasite invasion of RBCs depends on specificsurface moleculeson the RBCs
For P. vivaxduffy antigens
For P. falciparumglycophorin A
Most blackAfrican are duffy antigen negative but
not American blacks.
8/3/2019 8.Plasmodial Infections (Malaria)
31/42
HUMAN GENETICS AND MALARIA 1
Malaria is seldomly found in carriers of the sicklecell trait (Hbs or AS)
P. falciparuminfected RBCs adhere to the walls of
blood vessels via knobs that form as parasitesmature in RBCs (infected)
This sequestration causes the infected orparasitised RBCs to hide in an area of reduced O2
tension which then facilitates sickling / potassium
loss and killing of the parasite.
8/3/2019 8.Plasmodial Infections (Malaria)
32/42
HUMAN GENETICS AND MALARIA 2
Other genetic abnormalities that restrict the growth ofmalaria parasites within RBCs are
G6PDdeficiency and Thalassaemia
(decrease or total absence of a normalglobulin chain )
In this case there is a reduced ability for the RBCs toproduce NADPH via the pentose phosphate shunt,this results in an oxidative stress, which inhibits
parasite growth.
Also certain human leucocyte antigens (HLAS)common in West African also confer protectionagainst severe malaria.
Class 1 antigen HLABW53 and
Class 2 antigen HLADRB1.1302
8/3/2019 8.Plasmodial Infections (Malaria)
33/42
PATHOGENESIS AND CLINICAL
MANIFESTATIONS 1
The disease could be uncomplicated or complicated.
The main manifestations of malaria are fever, chillsand anaemia.
The typical malarial paroxysm coincides with thesimultaneous lysisof many RBCs and the releaseof large numbers of merozoites.
How these manifestations are maintained in vivo is
not clear (synchronous parasite development) Only the intra-ertythrocytic (asexual) parasites cause
disease.
8/3/2019 8.Plasmodial Infections (Malaria)
34/42
PATHOGENESIS AND CLINICAL
MANIFESTATIONS 2
There are 4 main processes. 1. Feverthe basis remain abscure
2. Anaemia
a. Haemolysis
b. Sequestration of infected RBCs in the spleen. 3. Tissue HypoxiaResulting from anaemia and
alteration in the microcirculation:- pulmonary oedema, renal failure, cerebraldysfunction.
4. Immunologic Events
These include hypoglobulinaemia;antibody mediated splenic sequestration of
platelets, immune complex disease,
8/3/2019 8.Plasmodial Infections (Malaria)
35/42
PATHOGENESIS AND CLINICAL
MANIFESTATIONS 3
CLINICALLY
The first symptoms are non-specific and resembleinfluenza and are similar for all 4 species. Non-
specific signs and symptoms include:
Fever (periodic, paroxysms)headaches,muscular ache / vague abdominal discomfort
/ lethargy / lassitude and dysphoria /temperature rise / loss of appetite, chills,hepatomegaly and anaemia, joint pains,sweating.
8/3/2019 8.Plasmodial Infections (Malaria)
36/42
PATHOGENESIS AND CLINICAL
MANIFESTATIONS 4
SPECIESSpecific syndromes P. vivaxand P. ovalefever and anaemia
debilitate the patient but is unusual.
P. malariaemortality is rare, it is most oftenassociated with immune complexdisease including an irreversibleglomerulonephritis in children in endemic
areas. P. falciparumcan cause lethal complications
especially in non immune persons andpregnant women.
8/3/2019 8.Plasmodial Infections (Malaria)
37/42
PATHOGENESIS AND CLINICAL
MANIFESTATIONS 5
Other complications associcted with severe P.falciparuminfections include:
Cerebral malariaHypoglycemia (especially in pregnantwomen)
Renal failure from acute tubular necrosis
Massive intracellular haemolysis (blackwater fever)
Pulmonary oedema
DIAGNOSIS
8/3/2019 8.Plasmodial Infections (Malaria)
38/42
DIAGNOSIS
Microscopic identification of parasites in blood is
the most certain method
Usually thin and thick blood films are prepared
The thick film is examined to detect thepresence of
the parasites
The thin film is examined to identify the species and
to give estimate of the level of parasitaemia
The films are stained in Giemsa stain or
Leishmans, or Fields stains
8/3/2019 8.Plasmodial Infections (Malaria)
39/42
ESTIMATION OF NUMBER OF
PARASITES
110 per 100 high power field --- + (1+)
11100 per --- ++ (2+)
110 in every high power field--- +++ (3+)
more than 10 in every high power field-- ++++ (4+)
8/3/2019 8.Plasmodial Infections (Malaria)
40/42
PREVENTION AND CONTROL
Avoiding mosquito bites
Use of drugs Prevention of mosquito breeding
Elimination of all adult mosquitoes
Health education Immunization
TREATMENT
8/3/2019 8.Plasmodial Infections (Malaria)
41/42
TREATMENT
Available antimalarials are in 3 broad groups
1. Quinoline-related CompoundsQuinines, quinidine, chloroquine, amodiaquine,mefloquine, Halofantrine, primaquine.
2.Antifols
Prymethamine, proguanil, chlorproguanil,trimethoprim
3. Artemisinin Compounds
Artemisinin, artemether, artesunate Of these three groups, theArtemisinin compounds
have the broadest time windowof action on asexualmalaria parasites from medium sized rings to early
shizonts.
8/3/2019 8.Plasmodial Infections (Malaria)
42/42
THANK YOU